20 Apr 2015
Open Access publisher BioMed Central and the Brazilian Retina and Vitreous Society are pleased to announce the launch of the International Journal of Retina and Vitreous (IJRV), the official journal of the Society. The journal will begin publishing in the second quarter of 2015.
The journal is focused on the ophthalmic subspecialty of vitreoretinal disorders and presents original articles on new approaches to diagnosis, outcomes of clinical trials, innovations in pharmacological therapy and surgical techniques, as well as basic science advances that impact clinical practice.
“Currently only a few journals focus specifically on the field of retina and vitreous”, said Editors-in-Chief, Jay Duker, Professor and Chair of Ophthalmology at Tufts University Medical Center in Boston, and Eduardo Rodrigues, Professor of Ophthalmology at Federal University of São Paulo. “As a result, many deserving manuscripts are not able to be published. The addition of another high quality journal concentrating on vitreoretinal disease would be a great contribution.”
Professors Duker and Rodrigues want interested readers to readily access the research, so there was no doubt that the journal had to be open access: “As avid readers of retinal publications, we are often bothered when we find an interesting paper but it is behind a pay wall and, thereby, restricting access to it.”
The Brazilian Retina and Vitreous Society has seen dramatic growth over the past two decades and currently counts nearly 900 retina specialists as members. “We now consider ourselves mature enough to flap our wings to reach out to the international retina community”, said BRVS President Andre Vieira Gomes.
President Gomes, who is also an associate editor for the journal, explains that the Society’s goal was to develop a unique, unparalleled journal of the highest quality. “We have invited and successfully recruited dedicated and renowned editors and collaborators, willing to deliver the best peer review journal that today’s authors expect. The journal presents a true opportunity for authors to have their work reviewed and appreciated in a very independent and reliable way”, he adds.
Initially, authors can publish their articles free of charge, as Professors Duker and Rodrigues explain: “We are so grateful and pleased that the Brazilian Retina and Vitreous Society will initially cover the costs of publication, making our journal free of charge for authors for the time being.”
Todd Hummel, Editorial Director, Clinical Medicine, at BioMed Central says, “We’re very pleased to welcome the Brazilian Retina and Vitreous Society and the International Journal of Retina and Vitreous to BioMed Central. The journal represents a tremendous milestone for the BRVS, and we’re delighted to support the society in this exciting endeavor.”
Please visit the journal’s website www.journalretinavitreous.com for further information and future updates.
T: +44 (0)20 3192 2054
Notes for editors
1. BioMed Central is an STM (Science, Technology and Medicine) publisher which has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector.